The global interbody fusion market was valued at over $3.1 billion in 2024.
It is projected to grow at a CAGR of 4.3% to surpass $4.2 billion by 2031.
The full report suite includes segmentation for:
Anterior Lumbar Interbody Fusion (ALIF)
Posterior Lumbar Interbody Fusion (PLIF)
Transforaminal Lumbar Interbody Fusion (TLIF)
Cervical Interbody Fusion (CIF)
VBR/Corpectomy
Expandable Interbody Devices
Market Data Included
Unit Sales
Average Selling Prices (ASPs)
Market Size & Growth Trends
Procedure Numbers
Market Drivers & Limiters
Market Forecasts Until 2031
Historical Data to 2024
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors
Global Interbody Fusion Device Market Trends
The primary limiter in the spinal fusion market is the rise of minimally invasive surgical (MIS) interbody devices.
MIS techniques reduce tissue trauma, lower complication rates, and shorten surgery duration.
Positive clinical outcomes have fueled adoption in mature markets and are expected to similarly affect emerging markets.
Preference for MIS over open techniques continues to impact growth potential of traditional interbody devices.
Global Interbody Fusion Device Market Share Insights
1 Medtronic
Market leader in 2024, with strong dominance in North America and parts of Asia-Pacific.
Key products include:
Elevate™ expandable cage
Anatomic® PTC and Cornerstone® PSR (cervical segment)
Capstone® cage, Cornerstone L ASR®, and other bone dowels/wedges
ARTiC™ line of 3D-printed metal devices
Medtronic also leads in VBR and expandable interbody segments.
2 DePuy Synthes
Second-largest global competitor in 2024.
Offers CFRP (carbon fiber reinforced polymer) lumbar interbody cages and various bone/non-bone devices.
Strong market presence in Western Europe and Asia-Pacific contributes significantly to its share.
3 Globus Medical / NuVasive
Major competitor post-2023 merger.
Anticipated to gain market share through:
Complementary global scale
Expanded commercial reach
Extensive product portfolio in spine and orthopedics
Strong surgeon engagement and R&D investment
Combined strengths position the merged entity for continued growth across all interbody subsegments.
Market Segmentation Summary
Anterior Lumbar Interbody Fusion (ALIF)
Posterior Lumbar Interbody Fusion (PLIF)
Transforaminal Lumbar Interbody Fusion (TLIF)
Cervical Interbody Fusion (CIF)
VBR/Corpectomy Devices
Expandable Interbody Devices
Research Scope Summary
Regions Covered
North America: Canada, United States
Latin America: Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
Western Europe: Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom
Central & Eastern Europe: Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine
Middle East: Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates
Asia Pacific: Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam
Africa: Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda
Base Year: 2024
Forecast Period: 2025–2031
Historical Data: 2021–2023
Quantitative Data
Procedure Numbers
Market Size
Market Shares
Market Forecasts
Market Growth Rates
Units Sold
Average Selling Prices
Qualitative Data
Market Growth Trends
Market Limiters
Competitive Analysis & SWOT for Top Competitors
Mergers & Acquisitions
Company Profiles
Product Portfolios
FDA Recalls
Disruptive Technologies
Disease Overviews
Data Sources
Primary Interviews with Industry Leaders
Government Physician Data
Regulatory Data
Hospital Private Data
Import & Export Data
iData Research Internal Database
- Interbody Fusion Market
- 7.1 Executive Summary
- 7.1.1 Global Interbody Fusion Market Overview
- 7.1.2 Competitive Analysis
- 7.1.3 Procedure Segmentation
- 7.1.4 Market Segmentation
- 7.1.5 Regions Included
- 7.2 Introduction
- 7.2.1 ALIF
- 7.2.2 PLIF
- 7.2.3 TLIF
- 7.2.4 CIF
- 7.2.5 VBR/Corpectomy
- 7.3 Procedure Numbers
- 7.3.1 Total Interbody Fusion Procedures
- 7.3.2 ALIF Procedures
- 7.3.3 PLIF Procedures
- 7.3.4 TLIF Procedures
- 7.3.5 CIF Procedures
- 7.3.6 VBR/Corpectomy Interbody Device Procedures
- 7.3.7 Expandable Interbody Device Procedures
- 7.4 Market Overview
- 7.4.1 By Segment
- 7.4.2 By Region
- 7.5 Market Analysis and Forecast
- 7.5.1 Total Interbody Fusion Market
- 7.5.2 ALIF Market
- 7.5.3 PLIF Market
- 7.5.4 TLIF Market
- 7.5.5 CIF Market
- 7.5.6 VBR/Corpectomy Interbody Device Market
- 7.5.7 Expandable Interbody Device Market
- 7.6 Drivers and Limiters
- 7.6.1 Market Drivers
- 7.6.2 Market Limiters
- 7.7 Competitive Market Share Analysis
- Chart 7-1: Interbody Fusion Market, Global, 2024 & 2031
- Chart 7-2: Interbody Fusion Procedures, Global, 2024
- Chart 7-3: Interbody Fusion Procedures by Region, Global, 2021 – 2031
- Chart 7-4: Interbody Fusion Device Market by Segment, Global, 2021 – 2031
- Chart 7-5: Interbody Fusion Device Market by Region, Global, 2021 – 2031
- Chart 7-6: Leading Competitors, Interbody Fusion Market, Global, 2024
- Figure 7-1: Interbody Fusion Procedure Segmentation
- Figure 7-2: Interbody Fusion Market Segmentation
- Figure 7-3: Interbody Fusion Regions Covered, Global (1 of 2)
- Figure 7-4: Interbody Fusion Regions Covered, Global (2 of 2)
- Figure 7-5: Interbody Fusion Procedures by Segment, Global, 2021 – 2031
- Figure 7-6: Interbody Fusion Procedures by Region, Global, 2021 – 2031
- Figure 7-7: Interbody Fusion Procedures by Country, North America, 2021 – 2031
- Figure 7-8: Interbody Fusion Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
- Figure 7-9: Interbody Fusion Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
- Figure 7-10: Interbody Fusion Procedures by Country, Western Europe, 2021 – 2031
- Figure 7-11: Interbody Fusion Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
- Figure 7-12: Interbody Fusion Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
- Figure 7-13: Interbody Fusion Procedures by Country, Middle East, 2021 – 2031
- Figure 7-14: Interbody Fusion Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
- Figure 7-15: Deformity Correction Thoracolumbar Fixation Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
- Figure 7-16: Deformity Correction Thoracolumbar Fixation Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
- Figure 7-17: Interbody Fusion Procedures by Country, Africa, 2021 – 2031
- Figure 7-18: ALIF Procedures by Region, Global, 2021 – 2031
- Figure 7-19: ALIF Procedures by Country, North America, 2021 – 2031
- Figure 7-20: ALIF Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
- Figure 7-21: Deformity Correction Thoracolumbar Fixation Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
- Figure 7-22: ALIF Procedures by Country, Western Europe, 2021 – 2031
- Figure 7-23: ALIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
- Figure 7-24: ALIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
- Figure 7-25: ALIF Procedures by Country, Middle East, 2021 – 2031
- Figure 7-26: ALIF Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
- Figure 7-27: ALIF Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
- Figure 7-28: ALIF Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
- Figure 7-29: ALIF Procedures by Country, Africa, 2021 – 2031
- Figure 7-30: PLIF Procedures by Region, Global, 2021 – 2031
- Figure 7-31: PLIF Procedures by Country, North America, 2021 – 2031
- Figure 7-32: PLIF Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
- Figure 7-33: PLIF Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
- Figure 7-34: PLIF Procedures by Country, Western Europe, 2021 – 2031
- Figure 7-35: PLIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
- Figure 7-36: PLIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
- Figure 7-37: PLIF Procedures by Country, Middle East, 2021 – 2031
- Figure 7-38: PLIF Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
- Figure 7-39: PLIF Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
- Figure 7-40: PLIF Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
- Figure 7-41: PLIF Procedures by Country, Africa, 2021 – 2031
- Figure 7-42: TLIF Procedures by Region, Global, 2021 – 2031
- Figure 7-43: TLIF Procedures by Country, North America, 2021 – 2031
- Figure 7-44: TLIF Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
- Figure 7-45: TLIF Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
- Figure 7-46: TLIF Procedures by Country, Western Europe, 2021 – 2031
- Figure 7-47: TLIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
- Figure 7-48: TLIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
- Figure 7-49: TLIF Procedures by Country, Middle East, 2021 – 2031
- Figure 7-50: TLIF Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
- Figure 7-51: TLIF Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
- Figure 7-52: TLIF Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
- Figure 7-53: TLIF Procedures by Country, Africa, 2021 – 2031
- Figure 7-54: CIF Procedures by Region, Global, 2021 – 2031
- Figure 7-55: CIF Procedures by Country, North America, 2021 – 2031
- Figure 7-56: CIF Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
- Figure 7-57: CIF Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
- Figure 7-58: CIF Procedures by Country, Western Europe, 2021 – 2031
- Figure 7-59: CIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
- Figure 7-60: CIF Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
- Figure 7-61: CIF Procedures by Country, Middle East, 2021 – 2031
- Figure 7-62: CIF Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
- Figure 7-63: CIF Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
- Figure 7-64: CIF Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
- Figure 7-65: CIF Procedures by Country, Africa, 2021 – 2031
- Figure 7-66: VBR/Corpectomy Procedures by Region, Global, 2021 – 2031
- Figure 7-67: VBR/Corpectomy Procedures by Country, North America, 2021 – 2031
- Figure 7-68: VBR/Corpectomy Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
- Figure 7-69: VBR/Corpectomy Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
- Figure 7-70: VBR/Corpectomy Procedures by Country, Western Europe, 2021 – 2031
- Figure 7-71: VBR/Corpectomy Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
- Figure 7-72: VBR/Corpectomy Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
- Figure 7-73: VBR/Corpectomy Procedures by Country, Middle East, 2021 – 2031
- Figure 7-74: VBR/Corpectomy Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
- Figure 7-75: VBR/Corpectomy Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
- Figure 7-76: VBR/Corpectomy Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
- Figure 7-77: VBR/Corpectomy Procedures by Country, Africa, 2021 – 2031
- Figure 7-78: Expandable Procedures by Region, Global, 2021 – 2031
- Figure 7-79: Expandable Procedures by Country, North America, 2021 – 2031
- Figure 7-80: Expandable Procedures by Country, Latin America, 2021 – 2031 (1 of 2)
- Figure 7-81: Expandable Procedures by Country, Latin America, 2021 – 2031 (2 of 2)
- Figure 7-82: Expandable Procedures by Country, Western Europe, 2021 – 2031
- Figure 7-83: Expandable Procedures by Country, Central & Eastern Europe, 2021 – 2031 (1 of 2)
- Figure 7-84: Expandable Procedures by Country, Central & Eastern Europe, 2021 – 2031 (2 of 2)
- Figure 7-85: Expandable Procedures by Country, Middle East, 2021 – 2031
- Figure 7-86: Expandable Procedures by Country, Asia-Pacific, 2021 – 2031 (1 of 3)
- Figure 7-87: Expandable Procedures by Country, Asia-Pacific, 2021 – 2031 (2 of 3)
- Figure 7-88: Expandable Procedures by Country, Asia-Pacific, 2021 – 2031 (3 of 3)
- Figure 7-89: Expandable Procedures by Country, Africa, 2021 – 2031
- Figure 7-90: Interbody Fusion Device Market by Segment, Global, 2021 – 2031 (US$M)
- Figure 7-91: Interbody Fusion Device Market by Region, Global, 2021 – 2031 (US$M)
- Figure 7-92: Interbody Fusion Market, Global, 2021 – 2031
- Figure 7-93: Units Sold by Region, Interbody Fusion Market, Global, 2021 – 2031
- Figure 7-94: Average Selling Price by Region, Interbody Fusion Market, Global, 2021 – 2031 (US$)
- Figure 7-95: Market Value by Region, Interbody Fusion Market, Global, 2021 – 2031 (US$M)
- Figure 7-96: ALIF Market, Global, 2021 – 2031
- Figure 7-97: Units Sold by Region, ALIF Market, Global, 2021 – 2031
- Figure 7-98: Average Selling Price by Region, ALIF Market, Global, 2021 – 2031 (US$)
- Figure 7-99: Market Value by Region, ALIF Market, Global, 2021 – 2031 (US$M)
- Figure 7-100: PLIF Market, Global, 2021 – 2031
- Figure 7-101: Units Sold by Region, PLIF Market, Global, 2021 – 2031
- Figure 7-102: Average Selling Price by Region, PLIF Market, Global, 2021 – 2031 (US$)
- Figure 7-103: Market Value by Region, PLIF Market, Global, 2021 – 2031 (US$M)
- Figure 7-104: TLIF Market, Global, 2021 – 2031
- Figure 7-105: Units Sold by Region, TLIF Market, Global, 2021 – 2031
- Figure 7-106: Average Selling Price by Region, TLIF Market, Global, 2021 – 2031 (US$)
- Figure 7-107: Market Value by Region, TLIF Market, Global, 2021 – 2031 (US$M)
- Figure 7-108: CIF Market, Global, 2021 – 2031
- Figure 7-109: Units Sold by Region, CIF Market, Global, 2021 – 2031
- Figure 7-110: Average Selling Price by Region, CIF Market, Global, 2021 – 2031 (US$)
- Figure 7-111: Market Value by Region, CIF Market, Global, 2021 – 2031 (US$M)
- Figure 7-112: VBR/Corpectomy Interbody Device Market, Global, 2021 – 2031
- Figure 7-113: Units Sold by Region, VBR/Corpectomy Interbody Device Market, Global, 2021 – 2031
- Figure 7-114: Average Selling Price by Region, VBR/Corpectomy Interbody Device Market, Global, 2021 – 2031 (US$)
- Figure 7-115: Market Value by Region, VBR/Corpectomy Interbody Device Market, Global, 2021 – 2031 (US$M)
- Figure 7-116: Expandable Interbody Device Market, Global, 2021 – 2031
- Figure 7-117: Units Sold by Region, Expandable Interbody Device Market, Global, 2021 – 2031
- Figure 7-118: Average Selling Price by Region, Expandable Interbody Device Market, Global, 2021 – 2031 (US$)
- Figure 7-119: Market Value by Region, Expandable Interbody Device Market, Global, 2021 – 2031 (US$M)
- Figure 7-120: Leading Competitors, Interbody Fusion Market, Global, 2024
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook